Brie Carter

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) received marketing authorization in Japan for their blockbuster drug Dupixent to treat severe asthma in children aged 6 to 11.

Benchmark has raised its Hut 8 price target to $85, saying the miner’s AI data centre deal delivers stronger, long-term cash flows with reduced risk.

BlackRock has elevated its spot Bitcoin ETF to a core investment theme, placing it alongside Treasury bills and top US technology stocks despite market volatility.

Gem Wallet has rolled out expanded cross-chain USDT support with integrated swaps, bridges and scam protection to simplify stablecoin transfers across multiple blockchains.

Palmer Luckey-backed digital bank Erebor has secured a $4.3 billion valuation as US regulators advance approvals that could pave the way for a full banking charter.

US regulators have charged several alleged crypto trading platforms and investment clubs over a $14 million social media scam that targeted retail investors with fake AI-driven trading schemes and non-existent token offerings.

Invion (ASX:IVX) announced that its partner, Hanlim Pharm, has secured non-dilutive funding, including support from the South Korean Government's Korea Drug Development Fund.

Venezuela is reportedly settling close to 80% of its crude oil export revenues using cryptocurrencies, primarily the USDT stablecoin, as traditional payment channels remain constrained by international sanctions.

Janus Henderson Group (NYSE:JHG) has entered into a definitive agreement to be acquired by Nelson Peltz’s Trian Fund Management and venture capital firm General Catalyst in an all-cash transaction valued at approximately $7.4 billion.